BRIEF—Dewpoint and Lonza lay off staff

19 January 2024

Swiss contract development and manufacturing organization (CDMO) Lonza has cut around 200 jobs at a manufacturing facility in California, USA.

The site is focused on the production of various components of biologic manufacturing, with news of the staff reductions coming through a government website set up for this purpose.

Another biotech company, Dewpoint Therapeutics, has also laid off around 15% of its staff, around 20 people, an update on the website shows.

Dewpoint is focused on developing biomolecular condensates, and is making the layoffs as part of an operational reorganization.

More Features in Biotechnology